PT Medela Potentia Tbk Posts Double-Digit Growth in FY2024, Approves IDR 137.4 Billion Dividend

PT Medela Potentia Tbk (IDX: MDLA) delivered robust financial results for the fiscal year 2024, underpinned by strong fundamentals and a disciplined execution of its strategic priorities. The company posted double-digit growth in both revenue and net income, reinforcing its position as a key player in Indonesia’s healthcare distribution and digital health ecosystem.

At its Annual General Meeting of Shareholders (AGMS) held in Jakarta, shareholders approved the distribution of a cash dividend totaling IDR 137.4 billion, or IDR 9.8 per share—equivalent to 40% of FY2024 net profit. The payout signals management’s confidence in MDLA’s financial resilience and commitment to sustained value creation for shareholders.

“Our 2024 performance reflects strong fundamentals and well-executed strategies. With a solid financial structure, measured operational expansion, and the support of our digital ecosystem, PT Medela Potentia Tbk is well-positioned for long-term growth,” said President Director Krestijanto Pandji..

In 2024, PT Medela Potentia Tbk reported net revenue of IDR 14.57 trillion, marking an 11.3% increase from the previous year, fueled by rising market demand and ongoing expansion of its healthcare distribution network. Net profit climbed 13.3% to IDR 343.27 billion, reflecting improved operational efficiency and strategic execution.

The company’s total assets grew to IDR 5.73 trillion, up from IDR 4.70 trillion in 2023, while equity rose 13.7% to IDR 2.21 trillion. Total liabilities stood at IDR 3.52 trillion, largely attributed to planned investments in logistics infrastructure, domestic manufacturing capabilities, and digital platform development.

Strategic Focus on Sustainable Growth

MDLA continues to advance its integrated business model, which is built on four core pillars: the nationwide distribution of pharmaceutical and healthcare products, the sales and marketing of medical devices, the local manufacturing of medical equipment, and the development of proprietary digital platforms such as GoApotik and GPOS. This strategic framework enables the company to operate across the healthcare value chain while enhancing service quality, efficiency, and accessibility.

With 35 branches and distribution centers nationwide, MDLA serves over 100,000 healthcare facilities across Indonesia. The company’s expansive footprint and digital capabilities position it to meet rising demand for affordable, accessible healthcare products.

 “We are investing in long-term growth through digitalization, supply chain optimization, and increased domestic production,” added Mr. Krestijanto. “Combined with strong governance and a forward-looking strategy, these investments support our commitment to delivering sustained value to both shareholders and stakeholders.”

In addition to approving the dividend, shareholders endorsed the 2024 annual report, appointed an independent public accounting firm for the 2025 audit, approved board remuneration, and reviewed the accountable use of IPO proceeds.

Looking ahead, MDLA expects continued momentum in Indonesia’s healthcare sector, driven by growing health awareness, increased demand for locally produced medical supplies, and accelerating digital transformation across the value chain.